The importance of Closed Container Integrity Testing to ensure the safety of Parenteral Drugs
Parenteral drugs are administered by means other than oral ingestion, typically through injection or infusion directly into the patient. This category includes all medications delivered via intravenous, intramuscular, or subcutaneous routes.
These products address a wide range of needs in the healthcare sector. Their mode of administration ensures that the intended effect is achieved quickly and safely, making them especially suitable for emergency situations. The parenteral route is also essential for delivering certain substances—such as insulin, peptide derivatives, and heparin—that would be poorly absorbed or degraded by the digestive system if taken orally.
Beyond medications, parenteral administration is also used to deliver nutritional solutions to patients who are unable to eat normally. While the parenteral route offers fast and effective treatment across a broad spectrum of conditions, it also requires rigorous quality control due to the rapid absorption of these products.
Types of parenteral products
Parenteral products are administered in several ways. The main routes are:
🔹 Intravenous (IV): Drugs are injected directly into the patient’s vein, typically in aqueous or hydroalcoholic solutions, and are rapidly absorbed. If large volumes (greater than 50 mL) need to be infused, an IV drip is generally used. Intravenous injections must be administered by trained personnel and dosed with care, as drugs delivered via this route have 100% bioavailability. IV medications are provided either in ready-to-use vials or in powder form that must be reconstituted prior to injection.
🔹 Intramuscular (IM): Intramuscular injections deliver drugs into the muscle tissue, using either aqueous solutions (which are absorbed quickly) or oil-based solutions (which absorb more slowly but provide prolonged effects). This route should also be performed by experienced personnel, as it can be painful and, if administered incorrectly, may lead to bacterial contamination or nerve injury.
🔹 Subcutaneous (SC): Commonly used for drugs such as insulin or vaccines, this route involves injecting the product into the fatty tissue just beneath the skin. Absorption is relatively slow, and only small volumes (up to 2 mL) can be administered. The key advantage of subcutaneous injections is their ease of use — they can often be performed by non-specialists or even by patients themselves. This makes the SC route especially suitable for medications requiring frequent administration. These injections can be given using standard or pre-filled syringes, or with pen devices that allow for easy, accurate dosing and reduced waste.
Regardless of the administration method, all parenteral products must be sterile. The contents of the vial or syringe may be ready to use or may require dilution with sterile water or other approved injection additives. In either case, the final solution must be free of contaminants and particulates, and be single-phase before administration.
Safety of Parenteral Products
International regulatory agencies such as the FDA, MHRA, and EMA require that 100% of all injectable drugs undergo testing. This is due to the nature of the parenteral route, where any non-compliance in product quality can pose serious risks to patient safety.
Container Closure Integrity Testing (CCIT) is a key method used to verify the integrity of these products, and it can be applied using several advanced techniques:
🔹 Vacuum Decay Method (VDM): This technique detects micro-leaks in the container that could compromise the product’s sterility and effectiveness over its entire shelf life.
🔹 Headspace Gas Analysis (HGA): HGA identifies abnormal concentrations of gases in the headspace of the container, which may signal contamination or a compromised seal.
🔹 Visual Inspection (VI): This method detects visible defects in both the container and its contents, such as scratches, inclusions, foreign particles, or other physical anomalies.
All of these techniques are non-destructive and allow for the testing of 100% of production batches without compromising product usability.
According to the most recent revision of USP <1207>, deterministic methods—like HGA and VDM—are preferred over probabilistic approaches for container closure integrity testing. While Visual Inspection is considered a probabilistic method, it still plays a valuable role. In particular, the integration of neural networks and AI-driven image recognition into VI processes has significantly enhanced their accuracy, reliability, and repeatability.
Citations
This article is inspired by information from Bonfiglioli Engineering.
- Bonfiglioli Engineering. “The importance of Closed Container Integrity Testing to ensure the safety of Parenteral Drugs” – Bonfiglioli Engineering, BONFIGLIOLI ENGINEERING S.r.l